INDUCTION OF INCREASED FIBRINOLYTIC ACTIVATOR IN PLASMA BY VARIOUS DRUGS.
D000227:Adenine Nucleotides; D000596:Amino Acids; D000818:Animals; D018926:Anti-Allergic Agents; D001285:Atropine; D002301:Cardiac Glycosides; D000697:Central Nervous System Stimulants; D003472:Curare; D003911:Dextrans; D004285:Dogs; D005342:Fibrinolysis; D006584:Hexamethonium Compounds; D006634:Histamine H1 Antagonists; D008333:Mandelic Acids; D009020:Morphine; D010277:Parasympathomimetics; D010600:Pharmacology; D051381:Rats; D012106:Research; D013501:Surface-Active Agents; D013565:Sympatholytics; D013566:Sympathomimetics
D000227:Adenine Nucleotides; D000596:Amino Acids; D018926:Anti-Allergic Agents; D002301:Cardiac Glycosides; D000697:Central Nervous System Stimulants; D003911:Dextrans; D006584:Hexamethonium Compounds; D006634:Histamine H1 Antagonists; D008333:Mandelic Acids; D010277:Parasympathomimetics; D013501:Surface-Active Agents; D013565:Sympatholytics; D013566:Sympathomimetics; D009020:Morphine; D001285:Atropine; D003472:Curare; C037938:mandelic acid
ADENINE NUCLEOTIDES; AMINO ACIDS; ANALEPTICS; ANTIHISTAMINICS; ATROPINE; CARDIAC GLYCOSIDES; CURARE; DEXTRAN; DOGS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; HEXAMETHONIUM COMPOUNDS; MANDELIC ACID; MORPHINE; PARASYMPATHOMIMETICS; PHARMACOLOGY; RATS; SURFACE-ACTIVE AGENTS; SYMPATHOLYTICS; SYMPATHOMIMETICS